We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
The Stroke journal publishes a study on the efficacy of the MethinksLVO program, which Vall d'Hebron has been using since last May for patients with suspected stroke.
Endovascular thrombectomy is indicated in case of ischemic stroke caused by a large vessel occlusion. In its effectiveness, the speed of diagnosis is crucial, since the treatment has to be done in the first hours. Vall d'Hebron is a pioneer in applying artificial intelligence software, MethinksLVO, to patients suspected of suffering a stroke, which detects where the occlusion of the large vessel that caused it is located. According to a study published in the journal Stroke, carried out from the observation of 1,453 patients from three Catalan centers (Vall d'Hebron, Germans Trias i Pujol and Hospital Clínic), this software can predict with a degree of accuracy of 87% occlusions of large vessels in patients with suspected stroke. The percentage increases to 91% if patient clinical data is incorporated into the software.
MethinksLVO, which Vall d'Hebron has been using since May 2020, is based on a machine learning algorithm that distinguishes occlusion patterns of a large vessel without the need to make a Computed Axial Tomography (CAT) scan with contrast. "In the diagnosis for stroke imaging, time is crucial. Generally, we perform a cranial CAT without contrast and then a CAT with contrast to see where the arterial occlusion is", summarizes Dr. Marc Ribó, neurologist at the Stroke Unit: "This artificial intelligence software allows us to save the step of acquiring X-ray images with contrast, a technology that is not available in many hospitals where patients go first: artificial intelligence avoids unnecessary transfers of patients to larger centers, with the consequent delay in performing endovascular thrombectomy".
In hospitals like Vall d'Hebron, the diagnosis of stroke can be accelerated by around 15 minutes thanks to artificial intelligence, calculates Dr. Marc Ribó, but in smaller health centers they can save up to two hours in applying the treatment. "The interpretation of images in real time by artificial intelligence algorithms has great potential to favor geographic equity in access to rapid diagnosis and treatment in regional centers or developing countries", concludes Dr. Marc Ribó.
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Vall d’Hebron University Hospital Foundation – Research Institute. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.